FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Related Tags >> GlaxoSmithKline   FDA   Eisai   chief medical officer
Syndicate content

Ligand Pharmaceuticals News

Most Popular Ligand Pharmaceuticals Story

Promacta gets FDA approval

The FDA has approved GlaxoSmithKline and Ligand Pharmaceuticals' Promacta (eltrombopag). The drug treats a rare immune condition called thrombocytopenia purpura, in which a patient's immune system... Read more...

Latest Headlines